Covered recipient · General Payments record
KIRANJEET KAUR
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2022–2024
$975.63
- Reported across 42 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $461.15 | 22 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $202.21 | 9 |
| Exact Sciences Corporation | $80.72 | 4 |
| PFIZER INC. | $57.64 | 3 |
| Astellas Pharma US Inc | $43.28 | 2 |
| GENZYME CORPORATION | $21.29 | 1 |
| Phadia US Inc. | $19.26 | 1 |
| Novo Nordisk AS | $18.59 | 1 |
| Xeris Pharmaceuticals, Inc. | $18.16 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (22)
Sorted by paying entity, then date · as published by CMS
Program year 2024 20222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Astellas Pharma US Inc | $18.28 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139469744 | CMS |
| Astellas Pharma US Inc | $25.00 | 05/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139513049 | CMS |
| Exact Sciences Corporation | $25.65 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114728934 | CMS |
| Exact Sciences Corporation | $13.20 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114728939 | CMS |
| Exact Sciences Corporation | $22.56 | 08/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114728945 | CMS |
| Exact Sciences Corporation | $19.31 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114728951 | CMS |
| GENZYME CORPORATION | $21.29 | 05/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139796342 | CMS |
| Lilly USA, LLC | $20.00 | 01/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135749465 | CMS |
| Lilly USA, LLC | $26.85 | 01/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135761436 | CMS |
| Lilly USA, LLC | $24.94 | 03/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135799802 | CMS |
| Lilly USA, LLC | $26.77 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135782064 | CMS |
| Lilly USA, LLC | $26.93 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135779400 | CMS |
| Lilly USA, LLC | $18.41 | 07/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135774804 | CMS |
| Lilly USA, LLC | $24.94 | 07/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135774806 | CMS |
| Lilly USA, LLC | $16.08 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135779398 | CMS |
| Lilly USA, LLC | $17.29 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135779402 | CMS |
| Novo Nordisk Inc | $18.59 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108565275 | CMS |
| PFIZER INC. | $18.47 | 01/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130892707 | CMS |
| PFIZER INC. | $18.80 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130925075 | CMS |
| PFIZER INC. | $20.37 | 12/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131083404 | CMS |
| Phadia US Inc. | $19.26 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1067581740 | CMS |
| Xeris Pharmaceuticals, Inc. | $18.16 | 08/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144631817 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.